Sober Sidekick, Siftwell team up on Medicaid SUD costs

Sober Sidekick and Siftwell Analytics announced a non-exclusive collaboration on Sept. 28, 2026, to help Medicaid managed care organizations identify members at risk of relapse-driven substance use disorder spending and intervene earlier. The partners plan to show health plans how analytics plus direct member support could reduce avoidable utilization and lower costs.

Why it matters: - Medicaid managed care organizations face pressure to cut avoidable spending while improving outcomes for members with substance use disorder. - The collaboration is aimed at one of the costliest and hardest-to-address drivers of spending: relapse-driven utilization. - The combined approach is designed to move health plans from identifying risk to intervening with members before costs escalate.

What happened: - Sober Sidekick, the peer recovery support platform operated by Empathy Health Technologies, and Siftwell Analytics announced a non-exclusive market collaboration on Sept. 28, 2026. - The partnership is designed to help Medicaid managed care organizations find and reduce high-cost, avoidable spending tied to substance use disorder. - The companies plan to present the joint offering to Association for Community Affiliated Plans member plans.

The details: - Siftwell's applied analytics platform surfaces data insights that help managed care plans identify members at risk of costly, avoidable utilization. - Sober Sidekick's relapse prevention platform provides the member-facing intervention intended to address the relapse events driving that spending. - The companies describe the combined model as a data-to-intervention pathway that helps plans identify who is at risk and act on that risk. - In joint market engagement, the companies plan to show how the two solutions work together to quantify avoidable SUD-related costs, target the right members and generate savings for plan partners. - Trey Sutten, CEO and co-founder of Siftwell, said the platforms solve two halves of the same problem for health plans. - Chris Thompson, CEO of Empathy Health Technologies and Sober Sidekick, said relapse-driven utilization is one of the largest, least-addressed drivers of avoidable spend. - The companies plan to expand the collaboration after ACAP, including joint go-to-market activity with shared managed care and Medicaid plan targets. - Sober Sidekick says the platform has been downloaded more than 1.4 million times and supports more than 100,000 monthly active members. - Independent analysis by Charm Economics and the Validation Institute found the platform associated with a 48.2% reduction in relapse and $4,442 in per-member-per-year savings, with a 2.19x total cost of care multiplier reported by ASPE/HHS. - Siftwell, founded in 2022 by managed care veterans, uses internal plan data plus external clinical, social and environmental signals to tell frontline teams who to reach, why and what to do. - Siftwell is headquartered in Charlotte, North Carolina. - Siftwell says its analytics support population health and cost of care, care quality and gap closure, growth and retention, and readiness for H.R. 1, the federal Medicaid reforms taking effect in 2027.

Between the lines: - The collaboration pairs predictive analytics with direct member engagement, which could make the offering more attractive to payers than a standalone analytics tool. - Both companies are positioning the partnership around measurable savings, suggesting the pitch is as much about financial performance as clinical improvement. - The ACAP audience points to a deliberate focus on community-oriented Medicaid plans that may be under the most pressure to manage behavioral health costs.

What's next: - Sober Sidekick and Siftwell plan to continue building the collaboration after ACAP. - The companies are preparing joint go-to-market efforts aimed at managed care and Medicaid plans. - More detail on how health plans will quantify savings and member impact is likely to follow as the partnership moves into market engagement.

The bottom line: - The partnership is a bid to help Medicaid plans spot relapse risk earlier and turn that insight into lower substance use disorder spending.